Ruxolitinib Plus LVP in Patients With R/R ETP-ALL

NCT03613428 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Acute T Cell Leukemia

Interventions

DRUG: Ruxolitinib
DRUG: Vincristine
DRUG: Prednisone

Sponsor

Sichuan University